| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B1 ERCC6L ABCA13 ATP8A2 CHD3 CHD4 DDX55 DDX46 ATP8A1 CHD5 MTREX DNAH5 ATP4A DYNC1H1 | 1.51e-05 | 441 | 162 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90B1 ERCC6L MYO7B ABCA13 ATP8A2 CHD3 CHD4 DDX55 DDX46 ATP8A1 CHD5 MYO3B MTREX DNAH5 ATP4A DYNC1H1 | 4.14e-05 | 614 | 162 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.24e-04 | 37 | 162 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | helicase activity | 3.11e-04 | 158 | 162 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 6.44e-04 | 5 | 162 | 2 | GO:0005519 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 6.44e-04 | 5 | 162 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 6.44e-04 | 5 | 162 | 2 | GO:0140444 | |
| GeneOntologyCellularComponent | sarcolemma | 1.26e-04 | 190 | 163 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | NuRD complex | 2.92e-04 | 17 | 163 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 2.92e-04 | 17 | 163 | 3 | GO:0090443 | |
| GeneOntologyCellularComponent | CHD-type complex | 2.92e-04 | 17 | 163 | 3 | GO:0090545 | |
| Domain | CHD_N | 6.65e-07 | 3 | 164 | 3 | IPR012958 | |
| Domain | CHD_C2 | 6.65e-07 | 3 | 164 | 3 | IPR012957 | |
| Domain | CHDCT2 | 6.65e-07 | 3 | 164 | 3 | PF08074 | |
| Domain | CHDNT | 6.65e-07 | 3 | 164 | 3 | PF08073 | |
| Domain | DUF1086 | 6.65e-07 | 3 | 164 | 3 | IPR009462 | |
| Domain | DUF1087 | 6.65e-07 | 3 | 164 | 3 | IPR009463 | |
| Domain | DUF1087 | 6.65e-07 | 3 | 164 | 3 | PF06465 | |
| Domain | DUF1086 | 6.65e-07 | 3 | 164 | 3 | PF06461 | |
| Domain | DUF1087 | 6.65e-07 | 3 | 164 | 3 | SM01147 | |
| Domain | DUF1086 | 6.65e-07 | 3 | 164 | 3 | SM01146 | |
| Domain | PolyA | 6.56e-06 | 5 | 164 | 3 | SM00517 | |
| Domain | - | 6.56e-06 | 5 | 164 | 3 | 1.10.1900.10 | |
| Domain | PABP | 6.56e-06 | 5 | 164 | 3 | PF00658 | |
| Domain | PABP_1234 | 6.56e-06 | 5 | 164 | 3 | IPR006515 | |
| Domain | PABC | 6.56e-06 | 5 | 164 | 3 | PS51309 | |
| Domain | PABP_HYD | 6.56e-06 | 5 | 164 | 3 | IPR002004 | |
| Domain | Helicase_C | 4.42e-05 | 107 | 164 | 7 | PF00271 | |
| Domain | HELICc | 4.42e-05 | 107 | 164 | 7 | SM00490 | |
| Domain | Helicase_C | 4.69e-05 | 108 | 164 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 4.98e-05 | 109 | 164 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.98e-05 | 109 | 164 | 7 | PS51192 | |
| Domain | DEXDc | 4.98e-05 | 109 | 164 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.28e-05 | 110 | 164 | 7 | IPR014001 | |
| Domain | ZF_SWIM | 5.37e-05 | 9 | 164 | 3 | PS50966 | |
| Domain | Znf_SWIM | 5.37e-05 | 9 | 164 | 3 | IPR007527 | |
| Domain | SNF2_N | 1.70e-04 | 32 | 164 | 4 | IPR000330 | |
| Domain | SNF2_N | 1.70e-04 | 32 | 164 | 4 | PF00176 | |
| Domain | SPEC | 1.70e-04 | 32 | 164 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.70e-04 | 32 | 164 | 4 | IPR018159 | |
| Domain | ARM-type_fold | GBF1 TOGARAM2 FRYL MEI1 TRRAP RYR3 FOCAD URB1 ATXN10 PRKDC FMNL1 | 2.08e-04 | 339 | 164 | 11 | IPR016024 |
| Domain | Znf_FYVE_PHD | 3.22e-04 | 147 | 164 | 7 | IPR011011 | |
| Domain | CH | 3.75e-04 | 70 | 164 | 5 | PF00307 | |
| Domain | - | 4.01e-04 | 71 | 164 | 5 | 1.10.418.10 | |
| Domain | KASH | 4.55e-04 | 4 | 164 | 2 | IPR012315 | |
| Domain | Cortactin-binding_p2_N | 4.55e-04 | 4 | 164 | 2 | IPR019131 | |
| Domain | SHR-BD | 4.55e-04 | 4 | 164 | 2 | IPR009543 | |
| Domain | KASH | 4.55e-04 | 4 | 164 | 2 | PS51049 | |
| Domain | KASH | 4.55e-04 | 4 | 164 | 2 | SM01249 | |
| Domain | KASH | 4.55e-04 | 4 | 164 | 2 | PF10541 | |
| Domain | VPS13_C | 4.55e-04 | 4 | 164 | 2 | PF16909 | |
| Domain | VPS13_C | 4.55e-04 | 4 | 164 | 2 | IPR031645 | |
| Domain | CortBP2 | 4.55e-04 | 4 | 164 | 2 | PF09727 | |
| Domain | SHR-BD | 4.55e-04 | 4 | 164 | 2 | PF06650 | |
| Domain | CH | 4.56e-04 | 73 | 164 | 5 | PS50021 | |
| Domain | Ion_trans_dom | 5.11e-04 | 114 | 164 | 6 | IPR005821 | |
| Domain | Ion_trans | 5.11e-04 | 114 | 164 | 6 | PF00520 | |
| Domain | CH-domain | 5.16e-04 | 75 | 164 | 5 | IPR001715 | |
| Domain | TPR_REGION | 6.45e-04 | 165 | 164 | 7 | PS50293 | |
| Domain | TPR | 6.45e-04 | 165 | 164 | 7 | PS50005 | |
| Domain | Znf_PHD-finger | 6.56e-04 | 79 | 164 | 5 | IPR019787 | |
| Domain | Autophagy-rel_C | 7.53e-04 | 5 | 164 | 2 | IPR015412 | |
| Domain | ATG_C | 7.53e-04 | 5 | 164 | 2 | PF09333 | |
| Domain | Spectrin | 1.03e-03 | 23 | 164 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.03e-03 | 23 | 164 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.03e-03 | 23 | 164 | 3 | PS00019 | |
| Domain | RRM_1 | 1.03e-03 | 23 | 164 | 3 | SM00361 | |
| Domain | Actinin_actin-bd_CS | 1.03e-03 | 23 | 164 | 3 | IPR001589 | |
| Domain | RRM_dom_euk | 1.03e-03 | 23 | 164 | 3 | IPR003954 | |
| Domain | FAT | 1.12e-03 | 6 | 164 | 2 | PS51189 | |
| Domain | FATC | 1.12e-03 | 6 | 164 | 2 | PS51190 | |
| Domain | FAT | 1.12e-03 | 6 | 164 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.12e-03 | 6 | 164 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.12e-03 | 6 | 164 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.12e-03 | 6 | 164 | 2 | IPR014009 | |
| Domain | FATC | 1.12e-03 | 6 | 164 | 2 | SM01343 | |
| Domain | PHD | 1.13e-03 | 89 | 164 | 5 | SM00249 | |
| Domain | Chromo_domain | 1.17e-03 | 24 | 164 | 3 | IPR023780 | |
| Domain | Znf_PHD | 1.24e-03 | 91 | 164 | 5 | IPR001965 | |
| Domain | Chromo | 1.49e-03 | 26 | 164 | 3 | PF00385 | |
| Domain | ZF_PHD_2 | 1.51e-03 | 95 | 164 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.58e-03 | 96 | 164 | 5 | PS01359 | |
| Domain | CHROMO_1 | 1.85e-03 | 28 | 164 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.85e-03 | 28 | 164 | 3 | PS50013 | |
| Domain | Spectrin_repeat | 2.05e-03 | 29 | 164 | 3 | IPR002017 | |
| Domain | Chorein_N | 2.07e-03 | 8 | 164 | 2 | PF12624 | |
| Domain | DHC_N1 | 2.07e-03 | 8 | 164 | 2 | PF08385 | |
| Domain | VPS13_N | 2.07e-03 | 8 | 164 | 2 | IPR026854 | |
| Domain | Dynein_heavy_dom-1 | 2.07e-03 | 8 | 164 | 2 | IPR013594 | |
| Domain | TPR-contain_dom | 2.11e-03 | 150 | 164 | 6 | IPR013026 | |
| Domain | Zinc_finger_PHD-type_CS | 2.56e-03 | 65 | 164 | 4 | IPR019786 | |
| Domain | CH | 2.56e-03 | 65 | 164 | 4 | SM00033 | |
| Domain | MYTH4 | 2.65e-03 | 9 | 164 | 2 | PS51016 | |
| Domain | MyTH4 | 2.65e-03 | 9 | 164 | 2 | SM00139 | |
| Domain | MyTH4_dom | 2.65e-03 | 9 | 164 | 2 | IPR000857 | |
| Domain | MyTH4 | 2.65e-03 | 9 | 164 | 2 | PF00784 | |
| Domain | - | 2.73e-03 | 32 | 164 | 3 | 3.40.1110.10 | |
| Domain | - | 2.73e-03 | 32 | 164 | 3 | 2.70.150.10 | |
| Domain | Chromodomain-like | 2.73e-03 | 32 | 164 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 2.99e-03 | 33 | 164 | 3 | IPR000953 | |
| Domain | CHROMO | 2.99e-03 | 33 | 164 | 3 | SM00298 | |
| Domain | ATPase_P-typ_cyto_domN | 3.54e-03 | 35 | 164 | 3 | IPR023299 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.54e-03 | 35 | 164 | 3 | IPR002464 | |
| Domain | ATPase_P-typ_P_site | 3.84e-03 | 36 | 164 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 3.84e-03 | 36 | 164 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 3.84e-03 | 36 | 164 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.15e-03 | 37 | 164 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.15e-03 | 37 | 164 | 3 | PF00122 | |
| Domain | PHD | 4.29e-03 | 75 | 164 | 4 | PF00628 | |
| Domain | DEAH_ATP_HELICASE | 4.48e-03 | 38 | 164 | 3 | PS00690 | |
| Domain | TPR-like_helical_dom | 4.58e-03 | 233 | 164 | 7 | IPR011990 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TFEB CDK17 CDK18 ARHGAP32 GBF1 MAP1B ERCC6L MATK FRYL PABPC1 DENND2B CEP350 KIAA1671 USP8 MTMR4 PHF3 SVIL SYNE2 ANKRD17 LIMCH1 CKAP2 MTREX UTRN GARRE1 EDRF1 GOLGA4 | 7.44e-14 | 861 | 166 | 26 | 36931259 |
| Pubmed | ZSWIM8 MAP1B PABPC4 UTP14A FRYL CHD4 TRRAP PABPC1 URB1 DDX46 PHF3 SYNE2 ANKRD17 PRKDC MTREX IK UTRN CAPRIN1 DYNC1H1 HERC5 PTCD3 | 7.01e-12 | 653 | 166 | 21 | 22586326 | |
| Pubmed | MAP9 HSP90B1 PCDHGB7 MAP1B PPRC1 ZSWIM5 RBBP8 SYNE1 PPP1R12B PABPC4 UTP14A CHD3 CHD4 DDX55 STK31 TRDN PABPC1 USP8 STRN COG1 PABPC3 CHD5 SYNE2 VPS13A FUNDC2 IRAK3 LIMCH1 PRKDC | 2.61e-10 | 1442 | 166 | 28 | 35575683 | |
| Pubmed | ZSWIM8 HSP90B1 REPS1 PPRC1 SYNE1 MCF2L2 PSMD4 CHD4 FRMD4B RYR3 CEP350 FOCAD PLEKHH1 USP8 NAA25 SERPINE2 COG1 ATXN10 PLCG1 PRKDC CKAP2 UTRN LCOR CAPRIN1 DYNC1H1 | 2.57e-09 | 1285 | 166 | 25 | 35914814 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CTTNBP2 MAP1B SYNE1 PPP1R12B PABPC4 TRPM2 PSMD4 CTTNBP2NL PPP1R2 CEP350 STRN PRKDC MAPK3 MTREX UTRN CAPRIN1 DYNC1H1 | 2.65e-09 | 573 | 166 | 17 | 28330616 |
| Pubmed | 3.25e-09 | 76 | 166 | 8 | 27542412 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSP90B1 MAP1B SYNE1 PABPC4 UTP14A CHD3 CHD4 TRRAP PABPC1 CEP350 KIAA1671 URB1 DDX46 SVIL SYNE2 PEX5 ATXN10 PRKDC MTREX IK UTRN DYNC1H1 | 4.33e-09 | 1024 | 166 | 22 | 24711643 |
| Pubmed | CDK17 CDK18 CTTNBP2 GBF1 FRYL CTTNBP2NL KIAA1671 USP8 STRN VPS33B PRKDC MTREX UTRN GARRE1 FMNL1 | 4.52e-09 | 446 | 166 | 15 | 24255178 | |
| Pubmed | ARHGAP32 HSP90B1 PPP1R12B TPTE2 WDR55 PSMD4 PPP1R2 CEP350 KIAA1671 MTMR4 VPS33B PDP1 SVIL SYNE2 VPS13A ATXN10 CKAP2 MAPK3 IK UTRN GOLGA4 | 3.36e-08 | 1049 | 166 | 21 | 27880917 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 ERCC6L RBBP8 MATK CHD3 CHD4 TRRAP CTTNBP2NL PPP1R2 DDX46 PHF3 SVIL KDM2B ANKRD17 LIMCH1 PRKDC MAPK3 GOLGA4 | 3.76e-08 | 774 | 166 | 18 | 15302935 |
| Pubmed | REPS1 SYNE1 PPP1R12B PABPC4 UTP14A WDR55 DDX55 TRRAP CTTNBP2NL GREB1L KIAA1671 STRN URB1 DDX46 GTF3C2 PHF3 KDM2B ANKRD17 LIMCH1 CKAP2 MTREX IK UTRN EDRF1 PTCD3 | 5.15e-08 | 1497 | 166 | 25 | 31527615 | |
| Pubmed | PDXDC1 REPS1 CCDC174 PABPC4 PSMD4 CTTNBP2NL PPP1R2 STRN COMMD8 PHF3 PABPC3 IK CAPRIN1 GOLGA4 | 7.16e-08 | 472 | 166 | 14 | 38943005 | |
| Pubmed | PPRC1 ZSWIM5 SYNE1 ZSWIM6 FOCAD PLEKHH1 USP8 PHF3 BTBD7 RHOBTB2 LIMCH1 DYNC1H1 VPS13B | 9.14e-08 | 407 | 166 | 13 | 12693553 | |
| Pubmed | UTP14A WDR55 PSMD4 CHD4 DDX55 CEP350 URB1 GTF3C2 ATXN10 PRKDC MTREX CAPRIN1 DYNC1H1 HERC5 | 9.49e-08 | 483 | 166 | 14 | 36912080 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 21940797 | ||
| Pubmed | CCDC174 PABPC4 CHD3 CHD4 PABPC1 VPS33B ANKRD17 PRKDC CAPRIN1 DYNC1H1 GOLGA4 | 2.21e-07 | 298 | 166 | 11 | 30737378 | |
| Pubmed | SERTAD2 SCRN1 DDX55 CTTNBP2NL FRMD4B DDX46 GTF3C2 CHD5 KDM2B ANKRD17 FAM149B1 MTREX LCOR GARRE1 | 2.86e-07 | 529 | 166 | 14 | 14621295 | |
| Pubmed | ARHGAP32 TCF3 CCDC174 KCMF1 PABPC4 UTP14A PSMD4 CHD3 TRRAP PABPC1 KIAA1671 GTF3C2 PABPC3 CHD5 SVIL SYNE2 KDM2B ANKRD17 ATXN10 CAPRIN1 GARRE1 DYNC1H1 PTCD3 | 3.56e-07 | 1429 | 166 | 23 | 35140242 | |
| Pubmed | PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family. | 4.26e-07 | 4 | 166 | 3 | 1437147 | |
| Pubmed | Early thymocyte development is regulated by modulation of E2A protein activity. | 4.26e-07 | 4 | 166 | 3 | 11560990 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSP90B1 REPS1 MAP1B ERCC6L UTP14A PSMD4 CHD3 CHD4 PABPC1 KIAA1671 USP8 DDX46 ANKRD17 PLCG1 PRKDC CKAP2 UTRN HERC5 | 5.95e-07 | 934 | 166 | 18 | 33916271 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TFEB CDK17 ZSWIM8 TCF3 ERCC6L CCDC174 KCMF1 PABPC4 UTP14A WDR55 FYCO1 PABPC1 FRMD4B CEP350 BTBD7 PEX5 LIMCH1 MTREX IK | 6.15e-07 | 1038 | 166 | 19 | 26673895 |
| Pubmed | GBF1 REPS1 RBM45 PABPC4 TRPM2 WDR55 CHD3 CHD4 DDX55 CWC25 PABPC1 CEP350 DDX46 PHF3 SVIL ANKRD17 LIMCH1 ATXN10 MTREX CAPRIN1 DYNC1H1 PTCD3 | 6.90e-07 | 1371 | 166 | 22 | 36244648 | |
| Pubmed | HSP90B1 PABPC4 CHD3 CHD4 DDX55 TRRAP PABPC1 URB1 DDX46 GTF3C2 PHF3 ANKRD17 ATXN10 PRKDC MTREX IK CAPRIN1 | 7.17e-07 | 847 | 166 | 17 | 35850772 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK17 NPR1 ERCC6L SYNE1 PPP1R12B PABPC4 PABPC1 CTTNBP2NL PPP1R2 CEP350 STRN URB1 DDX46 GTF3C2 SVIL PRKDC CAPRIN1 DYNC1H1 VPS13B PTCD3 | 7.23e-07 | 1155 | 166 | 20 | 20360068 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PHYKPL TCF3 KCNH8 MAP1B INPP5A TRPM2 CHD3 FRYL ZSWIM6 NXN TRRAP DENND2B KIAA1671 PLEKHH1 ANKRD17 LIMCH1 PLCG1 OLFM2 CKAP2 UTRN LCOR VPS13B GOLGA4 | 7.24e-07 | 1489 | 166 | 23 | 28611215 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSP90B1 SYNE1 PPP1R12B PABPC4 UTP14A CHD4 DDX55 PABPC1 DENND2B DDX46 CHD5 SVIL LIMCH1 PRKDC IK CAPRIN1 DYNC1H1 HERC5 | 7.48e-07 | 949 | 166 | 18 | 36574265 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B PABPC4 UTP14A CHD3 CHD4 DDX55 TRRAP URB1 DDX46 GTF3C2 PHF3 PRKDC CKAP2 MTREX IK HERC5 | 8.19e-07 | 759 | 166 | 16 | 35915203 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HSP90B1 MAP1B CHD4 TRRAP PABPC1 USP8 PABPC3 PLCG1 PRKDC CAPRIN1 DYNC1H1 | 9.11e-07 | 344 | 166 | 11 | 30333137 |
| Pubmed | HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. | 1.06e-06 | 5 | 166 | 3 | 19956697 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 33744966 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 GBF1 SYNE1 PABPC4 UTP14A PSMD4 CHD4 DDX55 PABPC1 URB1 GTF3C2 VPS33B ATXN10 PLCG1 PRKDC MTREX IK DNAH5 CAPRIN1 DYNC1H1 GOLGA4 PTCD3 | 1.30e-06 | 1425 | 166 | 22 | 30948266 |
| Pubmed | CDK17 MAP9 ARHGAP32 HSP90B1 CTTNBP2 MAP1B SYNE1 PPP1R12B PABPC4 SCRN1 CHD3 PABPC1 STRN ATP8A1 PABPC3 SVIL LIMCH1 MAPK3 UTRN CAPRIN1 DYNC1H1 PTCD3 | 1.40e-06 | 1431 | 166 | 22 | 37142655 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 10358005 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 MAP1B UTP14A PSMD4 CHD4 TRRAP PABPC1 URB1 FBXO22 GTF3C2 VPS33B ANKRD17 PLCG1 PRKDC MTREX IK UTRN CAPRIN1 DYNC1H1 GOLGA4 PTCD3 | 2.13e-06 | 1353 | 166 | 21 | 29467282 |
| Pubmed | 2.18e-06 | 44 | 166 | 5 | 38351062 | ||
| Pubmed | HSP90B1 REPS1 PPP1R12B KCMF1 PABPC4 UTP14A PSMD4 CHD4 PABPC1 PPP1R2 PHF3 SVIL KDM2B ANKRD17 LIMCH1 PRKDC MTREX IK CAPRIN1 DYNC1H1 | 2.33e-06 | 1247 | 166 | 20 | 27684187 | |
| Pubmed | ARHGAP32 HSP90B1 MAP1B PABPC4 E2F7 PSMD4 FRYL PABPC1 PRKDC MTREX IK CAPRIN1 PTCD3 | 2.73e-06 | 551 | 166 | 13 | 34728620 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 HSP90B1 SYNE1 PEX3 UTP14A PSMD4 DDX55 KIAA1671 STRN MIGA2 GTF3C2 HIBCH VPS33B SYNE2 VPS13A PEX5 FUNDC2 ATXN10 CKAP2 CAPRIN1 VPS13B PTCD3 | 2.87e-06 | 1496 | 166 | 22 | 32877691 |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 2.87e-06 | 182 | 166 | 8 | 31067453 | |
| Pubmed | CDK17 CDK18 HSP90B1 PABPC4 E2F7 PSMD4 CHD3 CHD4 PABPC1 DDX46 PABPC3 CHD5 PRKDC MAPK3 MTREX CAPRIN1 ATP4A DYNC1H1 PTCD3 | 2.88e-06 | 1153 | 166 | 19 | 29845934 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDXDC1 CDK17 GBF1 ERCC6L PABPC4 E2F7 PSMD4 FRYL NXN TRRAP PABPC1 PPP1R2 USP8 STRN NAA25 ATXN10 MTREX CAPRIN1 DYNC1H1 PTCD3 | 3.61e-06 | 1284 | 166 | 20 | 17353931 |
| Pubmed | Chromosomal localization of three human poly(A)-binding protein genes and four related pseudogenes. | 3.69e-06 | 7 | 166 | 3 | 10543404 | |
| Pubmed | NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome. | 3.69e-06 | 7 | 166 | 3 | 34784943 | |
| Pubmed | ARHGAP32 CTTNBP2 SYNE1 FYCO1 CHD4 PABPC1 STRN PABPC3 SVIL SYNE2 PEX5 ANKRD17 LIMCH1 MAPK3 CAPRIN1 DYNC1H1 GOLGA4 | 4.03e-06 | 963 | 166 | 17 | 28671696 | |
| Pubmed | 4.14e-06 | 255 | 166 | 9 | 15324660 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | HSP90B1 MAP1B UTP14A LAMB3 CHD3 TRRAP ATXN10 IK UTRN CAPRIN1 PTCD3 | 4.92e-06 | 410 | 166 | 11 | 26949251 |
| Pubmed | HSP90B1 REPS1 MAP1B PABPC4 PSMD4 CHD4 KIAA1671 URB1 DDX46 COG1 COMMD8 SYNE2 IFI44L LIMCH1 PRKDC MTREX CAPRIN1 GARRE1 DYNC1H1 HERC5 PTCD3 | 5.59e-06 | 1440 | 166 | 21 | 30833792 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TFEB GBF1 REPS1 PPRC1 LAMB3 FYCO1 FRYL TRRAP SH2B2 FOCAD URB1 KLHL25 BTBD7 CHD5 PLCG1 PRKDC TTC38 DYNC1H1 | 6.25e-06 | 1105 | 166 | 18 | 35748872 |
| Pubmed | 6.69e-06 | 55 | 166 | 5 | 33067418 | ||
| Pubmed | 7.39e-06 | 274 | 166 | 9 | 34244482 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSP90B1 PABPC4 UTP14A LAMB3 DDX55 PABPC1 KIAA1671 PHF3 CHD5 SVIL ANKRD17 PRKDC CKAP2 MTREX IK CAPRIN1 ATP4A DYNC1H1 PTCD3 | 9.82e-06 | 1257 | 166 | 19 | 36526897 |
| Pubmed | 1.07e-05 | 156 | 166 | 7 | 37108203 | ||
| Pubmed | Identification of a Nuclear Exosome Decay Pathway for Processed Transcripts. | 1.25e-05 | 10 | 166 | 3 | 27871484 | |
| Pubmed | ARHGAP32 ERCC6L PRICKLE1 STK31 TRDN CEP350 PLEKHH1 USP8 SYNE2 VPS13A KDM2B ANKRD17 IRAK3 | 1.31e-05 | 638 | 166 | 13 | 31182584 | |
| Pubmed | HGF HSP90B1 GBF1 ERCC6L PEX3 FYCO1 CHD4 DDX55 PABPC1 CEP350 ATP8A1 CHD5 ANKRD17 ATXN10 PRKDC CAPRIN1 FMNL1 DYNC1H1 | 1.32e-05 | 1168 | 166 | 18 | 19946888 | |
| Pubmed | 1.36e-05 | 225 | 166 | 8 | 12168954 | ||
| Pubmed | MAP1B UTP14A CHD4 DDX55 CEP350 GTF3C2 ANKRD17 LIMCH1 PRKDC IK HERC5 PTCD3 | 1.38e-05 | 547 | 166 | 12 | 37267103 | |
| Pubmed | REPS1 MAP1B ERCC6L TRRAP KIAA1671 DDX46 GTF3C2 PHF3 KDM2B PRKDC IK DYNC1H1 | 1.43e-05 | 549 | 166 | 12 | 38280479 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PDXDC1 HSP90B1 MAP1B PABPC4 LAMB3 PSMD4 PABPC1 PABPC3 LIMCH1 ATXN10 PRKDC DYNC1H1 PTCD3 | 1.52e-05 | 647 | 166 | 13 | 26618866 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.70e-05 | 232 | 166 | 8 | 25515538 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MAP9 TCF3 PPP1R12B PEX3 PABPC4 FYCO1 PABPC1 CEP350 URB1 COMMD8 FUNDC2 LIMCH1 MAPK3 MTREX | 1.71e-05 | 754 | 166 | 14 | 33060197 |
| Pubmed | ERRgamma regulates cardiac, gastric, and renal potassium homeostasis. | 1.71e-05 | 11 | 166 | 3 | 19965931 | |
| Pubmed | 1.77e-05 | 67 | 166 | 5 | 29254152 | ||
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 2.26e-05 | 2 | 166 | 2 | 7560064 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16239571 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 18752298 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 11792814 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12498815 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.26e-05 | 2 | 166 | 2 | 24931616 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 7575689 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 10534404 | ||
| Pubmed | TRPM2 Is Not Required for T-Cell Activation and Differentiation. | 2.26e-05 | 2 | 166 | 2 | 35095852 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 29928062 | ||
| Pubmed | Substrate specificity of human kallikreins 1 and 6 determined by phage display. | 2.26e-05 | 2 | 166 | 2 | 18359858 | |
| Pubmed | Nucleotide sequence of a mouse testis poly(A) binding protein cDNA. | 2.26e-05 | 2 | 166 | 2 | 1630930 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22147896 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19729483 | ||
| Pubmed | Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse. | 2.26e-05 | 2 | 166 | 2 | 7893484 | |
| Pubmed | DNA-dependent protein kinase promotes DNA end processing by MRN and CtIP. | 2.26e-05 | 2 | 166 | 2 | 31934630 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22768332 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19020299 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 26885753 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16393973 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 26971890 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.26e-05 | 2 | 166 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.26e-05 | 2 | 166 | 2 | 24718612 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24586179 | ||
| Pubmed | Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis. | 2.26e-05 | 2 | 166 | 2 | 10954604 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 35065666 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17761684 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 9732454 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31578382 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16111632 | ||
| Pubmed | The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte. | 2.26e-05 | 2 | 166 | 2 | 8706129 | |
| Pubmed | PRICKLE1 × FOCAD Interaction Revealed by Genome-Wide vQTL Analysis of Human Facial Traits. | 2.26e-05 | 2 | 166 | 2 | 34434215 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17296939 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 14662857 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 9278319 | ||
| Pubmed | Effect of different Ig transgenes on B cell differentiation in scid mice. | 2.26e-05 | 2 | 166 | 2 | 9088976 | |
| Interaction | ATOH1 interactions | 2.60e-07 | 80 | 162 | 8 | int:ATOH1 | |
| Interaction | GOLGA1 interactions | PDXDC1 GBF1 ERCC6L CEP350 KIAA1671 STRN FBXO22 COG1 PEX5 ATXN10 GOLGA4 | 2.79e-07 | 183 | 162 | 11 | int:GOLGA1 |
| Interaction | SIRT7 interactions | ZSWIM8 MAP1B PABPC4 UTP14A FRYL CHD4 TRRAP PABPC1 URB1 DDX46 PHF3 SYNE2 ANKRD17 PRKDC MTREX IK UTRN CAPRIN1 DYNC1H1 HERC5 PTCD3 | 5.83e-07 | 744 | 162 | 21 | int:SIRT7 |
| Interaction | YWHAG interactions | TFEB CDK17 CDK18 HGF ARHGAP32 GBF1 ERCC6L PABPC4 FRYL TRRAP PABPC1 DENND2B CEP350 KIAA1671 USP8 MTMR4 PHF3 SVIL SYNE2 ANKRD17 PRKDC CKAP2 MAPK3 MTREX UTRN GARRE1 EDRF1 DYNC1H1 | 7.15e-07 | 1248 | 162 | 28 | int:YWHAG |
| Interaction | SFN interactions | ARHGAP32 HSP90B1 TCF3 GBF1 MAP1B ERCC6L FRYL PABPC1 DENND2B PPP1R2 CEP350 KIAA1671 USP8 MTMR4 PHF3 SVIL ANKRD17 MTREX GARRE1 | 3.14e-06 | 692 | 162 | 19 | int:SFN |
| Interaction | HSP90AB1 interactions | CDK18 HSP90B1 GBF1 MAP1B RBM45 RBBP8 PSMD4 CHD3 TRDN CTTNBP2NL KIAA1671 USP8 DDX46 RHOBTB2 MYO3B SVIL VPS13A PLCG1 PRKDC MAPK3 MAPK13 EDRF1 | 9.20e-06 | 960 | 162 | 22 | int:HSP90AB1 |
| Interaction | MB interactions | 1.42e-05 | 19 | 162 | 4 | int:MB | |
| Interaction | PIP interactions | 1.62e-05 | 181 | 162 | 9 | int:PIP | |
| Interaction | LUC7L2 interactions | PABPC4 CHD3 CHD4 PABPC1 NAA25 DDX46 FBXO22 PABPC3 SVIL IK DYNC1H1 PTCD3 | 2.96e-05 | 353 | 162 | 12 | int:LUC7L2 |
| Interaction | NPM1 interactions | TCF3 RBM44 MAP1B RBM45 PABPC4 UTP14A WDR55 PSMD4 CHD3 CHD4 DDX55 TRRAP TRDN PABPC1 ADGB URB1 SYNE2 LIMCH1 PLCG1 PRKDC UTRN FMNL1 HERC5 PTCD3 | 3.33e-05 | 1201 | 162 | 24 | int:NPM1 |
| Interaction | DNAJC7 interactions | PABPC4 TRRAP FBXO22 GTF3C2 SVIL VPS13A FUNDC2 ATXN10 PRKDC LCOR EDRF1 VPS13B HERC5 | 4.11e-05 | 425 | 162 | 13 | int:DNAJC7 |
| Interaction | PAPOLB interactions | 5.87e-05 | 10 | 162 | 3 | int:PAPOLB | |
| Interaction | ADGB interactions | 5.87e-05 | 10 | 162 | 3 | int:ADGB | |
| Interaction | CTNNB1 interactions | ARHGAP32 HSP90B1 TCF3 PPP1R12B PABPC4 UTP14A PSMD4 CHD4 TRRAP PABPC1 KIAA1671 USP8 GLIS2 SVIL SYNE2 LIMCH1 PRKDC UTRN CAPRIN1 DYNC1H1 HERC5 | 6.11e-05 | 1009 | 162 | 21 | int:CTNNB1 |
| Interaction | PPP2CB interactions | CDK17 CDK18 CTTNBP2 SERTAD2 CTTNBP2NL CEP350 STRN IK GOLGA4 HERC5 | 6.23e-05 | 267 | 162 | 10 | int:PPP2CB |
| Interaction | IFI16 interactions | HSP90B1 MAP1B SYNE1 PABPC4 UTP14A E2F7 CHD4 DDX55 PABPC1 URB1 GTF3C2 SVIL ATXN10 MAPK3 MTREX CAPRIN1 HERC5 | 6.46e-05 | 714 | 162 | 17 | int:IFI16 |
| Interaction | YWHAB interactions | TFEB CDK17 CDK18 ARHGAP32 GBF1 PABPC4 FRYL TRRAP DENND2B CEP350 KIAA1671 USP8 SLC8A3 MTMR4 VPS33B PHF3 SVIL ANKRD17 MTREX GARRE1 DYNC1H1 | 6.55e-05 | 1014 | 162 | 21 | int:YWHAB |
| Interaction | ITGB3 interactions | 7.13e-05 | 170 | 162 | 8 | int:ITGB3 | |
| Interaction | YWHAH interactions | TFEB CDK17 CDK18 ARHGAP32 GBF1 ERCC6L FRYL DENND2B CEP350 KIAA1671 USP8 MTMR4 PHF3 SVIL SYNE2 ANKRD17 LIMCH1 MTREX UTRN GARRE1 EDRF1 GOLGA4 | 7.43e-05 | 1102 | 162 | 22 | int:YWHAH |
| Interaction | PSMD3 interactions | MAP1B ZFAND2B PEX3 KCMF1 PSMD4 CCDC92 TRRAP PABPC1 STRN VPS33B DYNC1H1 GOLGA4 | 7.73e-05 | 390 | 162 | 12 | int:PSMD3 |
| Interaction | JPH3 interactions | 7.93e-05 | 55 | 162 | 5 | int:JPH3 | |
| Interaction | MEX3B interactions | PABPC4 NXN PABPC1 KIAA1671 ANKRD17 CAPRIN1 GARRE1 EDRF1 PTCD3 | 7.99e-05 | 222 | 162 | 9 | int:MEX3B |
| Interaction | CIT interactions | RAG1 ARHGAP32 HSP90B1 SYNE1 PABPC4 UTP14A PCDHA6 CHD3 CHD4 TRRAP PABPC1 KIAA1671 URB1 MTMR4 DDX46 FBXO22 GTF3C2 PABPC3 SVIL SYNE2 PRKDC MTREX IK CAPRIN1 DYNC1H1 GOLGA4 | 9.31e-05 | 1450 | 162 | 26 | int:CIT |
| Interaction | PPIA interactions | PDXDC1 CACNA1D REPS1 MAP1B CCDC174 PABPC4 PSMD4 TRRAP CTTNBP2NL PPP1R2 STRN DDX46 COMMD8 PHF3 PABPC3 RHOBTB2 IK CAPRIN1 GOLGA4 | 9.80e-05 | 888 | 162 | 19 | int:PPIA |
| Interaction | EZH1 interactions | 9.91e-05 | 92 | 162 | 6 | int:EZH1 | |
| Interaction | USP36 interactions | UTP14A WDR55 PSMD4 CHD3 CHD4 DDX55 CEP350 URB1 GTF3C2 ATXN10 PRKDC MTREX CAPRIN1 DYNC1H1 HERC5 | 1.02e-04 | 599 | 162 | 15 | int:USP36 |
| Interaction | TAL1 interactions | 1.05e-04 | 93 | 162 | 6 | int:TAL1 | |
| Interaction | IVNS1ABP interactions | 1.06e-04 | 180 | 162 | 8 | int:IVNS1ABP | |
| Interaction | DNAH10 interactions | 1.07e-04 | 31 | 162 | 4 | int:DNAH10 | |
| Interaction | PRC1 interactions | HSP90B1 GBF1 ATP8A2 SYNE1 PABPC4 CHD4 TRRAP PABPC1 KIAA1671 URB1 DDX46 PABPC3 CHD5 TM7SF2 ATXN10 PRKDC CKAP2 IK CAPRIN1 DYNC1H1 | 1.10e-04 | 973 | 162 | 20 | int:PRC1 |
| Interaction | STK38 interactions | 1.15e-04 | 182 | 162 | 8 | int:STK38 | |
| Interaction | HSF1 interactions | HSP90B1 REPS1 PABPC4 CHD3 CHD4 TRRAP PABPC1 GTF3C2 HIBCH COG1 SYNE2 KDM2B LIMCH1 PRKDC MAPK3 | 1.22e-04 | 609 | 162 | 15 | int:HSF1 |
| Interaction | USP7 interactions | ANKRD31 TCF3 ERCC6L RBM45 MYO7B SYNE1 TOGARAM2 PSMD4 STK31 TRRAP PABPC1 PPP1R2 KLHL5 FBXO22 STXBP6 SVIL FUNDC2 IRAK3 MTREX DNAH5 UTRN LCOR DYNC1H1 VPS13B | 1.34e-04 | 1313 | 162 | 24 | int:USP7 |
| Interaction | DDX23 interactions | MAP1B SYNE1 UTP14A CHD3 CHD4 DDX55 CWC25 TRRAP URB1 DDX46 FBXO22 PHF3 IK | 1.40e-04 | 480 | 162 | 13 | int:DDX23 |
| Interaction | PRMT1 interactions | ARHGAP32 HSP90B1 GBF1 MAP1B RBM45 PABPC4 E2F7 SCRN1 PSMD4 FRYL PABPC1 NFATC2IP PRKDC MTREX IK IGSF21 CAPRIN1 GOLGA4 PTCD3 | 1.76e-04 | 929 | 162 | 19 | int:PRMT1 |
| Interaction | PAN3 interactions | 1.77e-04 | 65 | 162 | 5 | int:PAN3 | |
| Interaction | SQSTM1 interactions | ARHGAP32 GBF1 MAP1B ERCC6L RBM45 PABPC4 PSMD4 FRYL PABPC1 CEP350 KIAA1671 USP8 MTMR4 SERPINE2 COMMD8 PEX5 ATXN10 MAPK3 IK MAPK13 UTRN EDRF1 DYNC1H1 | 1.84e-04 | 1257 | 162 | 23 | int:SQSTM1 |
| Interaction | STRIP2 interactions | 2.19e-04 | 68 | 162 | 5 | int:STRIP2 | |
| Interaction | SGK3 interactions | 2.34e-04 | 69 | 162 | 5 | int:SGK3 | |
| Interaction | U2AF2 interactions | HSP90B1 MAP1B ARHGAP36 PABPC4 LAMB3 CHD3 CHD4 PABPC1 DDX46 GLIS2 PRKDC IK CAPRIN1 DYNC1H1 GOLGA4 | 2.52e-04 | 651 | 162 | 15 | int:U2AF2 |
| Interaction | SMG7 interactions | ZSWIM8 PABPC1 MTMR4 VPS33B CHD5 KDM2B ANKRD17 CAPRIN1 GARRE1 PTCD3 | 2.66e-04 | 319 | 162 | 10 | int:SMG7 |
| Interaction | POU5F1 interactions | TFEB KCMF1 CHD3 CHD4 TRRAP GTF3C2 PHF3 CHD5 KDM2B ANKRD17 ATXN10 PRKDC DYNC1H1 PTCD3 | 2.73e-04 | 584 | 162 | 14 | int:POU5F1 |
| Interaction | DOT1L interactions | HSP90B1 RBM45 PABPC4 CHD3 CHD4 DDX55 TRRAP PABPC1 URB1 DDX46 GTF3C2 PHF3 ATXN10 PRKDC MTREX IK CAPRIN1 | 2.79e-04 | 807 | 162 | 17 | int:DOT1L |
| Interaction | BMI1 interactions | SYNE1 PABPC4 CHD3 CHD4 RYR3 PHF3 PABPC3 KDM2B PLCG1 PRKDC MTREX IK CAPRIN1 DYNC1H1 PTCD3 | 2.87e-04 | 659 | 162 | 15 | int:BMI1 |
| Interaction | TOP3B interactions | TFEB HSP90B1 GBF1 REPS1 PPRC1 KCMF1 LAMB3 FYCO1 FRYL TRRAP PABPC1 SH2B2 FOCAD URB1 FBXO22 KLHL25 BTBD7 CHD5 SVIL ANKRD17 PLCG1 PRKDC CAPRIN1 TTC38 DYNC1H1 | 2.91e-04 | 1470 | 162 | 25 | int:TOP3B |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q24 | 1.95e-04 | 78 | 167 | 4 | chr6q24 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 1.84e-05 | 9 | 111 | 3 | 90 | |
| GeneFamily | PHD finger proteins|NuRD complex | 4.76e-05 | 12 | 111 | 3 | 1305 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.22e-04 | 4 | 111 | 2 | 1252 | |
| GeneFamily | PHD finger proteins | 2.31e-04 | 90 | 111 | 5 | 88 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.38e-04 | 20 | 111 | 3 | 1371 | |
| GeneFamily | RNA binding motif containing | 2.02e-03 | 213 | 111 | 6 | 725 | |
| GeneFamily | Mitogen-activated protein kinases | 2.79e-03 | 13 | 111 | 2 | 651 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.58e-03 | 50 | 111 | 3 | 1293 | |
| GeneFamily | ATPase phospholipid transporting | 3.72e-03 | 15 | 111 | 2 | 1210 | |
| GeneFamily | Kallikreins | 4.24e-03 | 16 | 111 | 2 | 616 | |
| GeneFamily | AAA ATPases|Peroxins | 4.24e-03 | 16 | 111 | 2 | 957 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.36e-03 | 18 | 111 | 2 | 91 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | CDK18 GBF1 GALT SYNE1 TRPM2 LAMB3 CHD4 ITGA7 DENND2B CEP350 PHF3 SVIL SYNE2 PEX5 PLCG1 TTC38 | 7.66e-07 | 567 | 167 | 16 | M16909 |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | CACNA1D ARHGAP32 INPP5A MATK FRMD4B BTBD7 PRKDC MTREX VPS13B | 4.53e-06 | 194 | 167 | 9 | M8017 |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 1.80e-05 | 176 | 167 | 8 | M8248 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | PPRC1 SERTAD2 FRYL CEP350 STRN PHF3 VPS13A IFI44L EDRF1 VPS13B | 2.41e-05 | 300 | 167 | 10 | M8702 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TFEB MAP1B PRICKLE1 SYNE1 PPP1R12B FYCO1 CHD3 CHD4 ITGA7 FRMD4B FOCAD KLHL5 STRN MTMR4 ATP8A1 MIGA2 GLIS2 SVIL PEX5 GOLGA4 | 2.55e-05 | 1102 | 167 | 20 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TFEB MAP1B PRICKLE1 SYNE1 PPP1R12B FYCO1 CHD3 CHD4 ITGA7 FRMD4B FOCAD KLHL5 STRN MTMR4 ATP8A1 MIGA2 GLIS2 SVIL PEX5 GOLGA4 | 3.37e-05 | 1124 | 167 | 20 | MM1070 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 3.42e-05 | 250 | 167 | 9 | M11318 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK17 GBF1 MAP1B PEX3 FRYL TRRAP DENND2B CEP350 GTF3C2 PHF3 SYNE2 VPS13A ANKRD17 MTREX GARRE1 VPS13B GOLGA4 | 3.55e-05 | 856 | 167 | 17 | M4500 |
| Coexpression | BILD_SRC_ONCOGENIC_SIGNATURE | 3.75e-05 | 59 | 167 | 5 | M116 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 4.33e-05 | 199 | 167 | 8 | M3474 | |
| Coexpression | GSE6875_TCONV_VS_FOXP3_KO_TREG_DN | 4.49e-05 | 200 | 167 | 8 | M6802 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK17 MAP1B PEX3 FRYL TRRAP CEP350 PHF3 VPS13A ANKRD17 LIMCH1 MTREX GOLGA4 | 4.73e-05 | 466 | 167 | 12 | M13522 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PHYKPL REPS1 MAP1B CHD4 FRMD4B PLEKHH1 KLHL5 STXBP6 COG1 COMMD8 SYNE2 AEBP2 CKAP2 EDRF1 DYNC1H1 GOLGA4 | 1.25e-05 | 595 | 161 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | MAP9 FRYL CEP350 USP8 STRN PRKDC UTRN CAPRIN1 DYNC1H1 VPS13B | 3.29e-09 | 193 | 167 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SYNE1 MCF2L2 FRYL NFATC2IP SYNE2 VPS13A IFI44L PLCG1 UTRN VPS13B | 3.29e-09 | 193 | 167 | 10 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CDK17 SYNE1 FRYL PHF3 SYNE2 VPS13A IFI44L UTRN VPS13B GOLGA4 | 4.42e-09 | 199 | 167 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | MAP1B PPP1R12B SCRN1 CEP350 KLHL5 PHF3 SYNE2 LIMCH1 UTRN GOLGA4 | 4.42e-09 | 199 | 167 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.91e-08 | 200 | 167 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.91e-08 | 200 | 167 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.18e-07 | 197 | 167 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 8.83e-07 | 199 | 167 | 8 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.09e-06 | 156 | 167 | 7 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 3.29e-06 | 167 | 167 | 7 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-06 | 174 | 167 | 7 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-06 | 181 | 167 | 7 | a8e9ea73c24109a5d4d28bc0577cc869ad932a4d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.01e-06 | 183 | 167 | 7 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.92e-06 | 187 | 167 | 7 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 187 | 167 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-06 | 188 | 167 | 7 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 7.17e-06 | 188 | 167 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.42e-06 | 189 | 167 | 7 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-06 | 191 | 167 | 7 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.95e-06 | 191 | 167 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-06 | 194 | 167 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.80e-06 | 194 | 167 | 7 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.80e-06 | 194 | 167 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 195 | 167 | 7 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.09e-06 | 195 | 167 | 7 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 9.72e-06 | 197 | 167 | 7 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 9.72e-06 | 197 | 167 | 7 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.00e-05 | 198 | 167 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 199 | 167 | 7 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 199 | 167 | 7 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-05 | 199 | 167 | 7 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 199 | 167 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 199 | 167 | 7 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-05 | 199 | 167 | 7 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.07e-05 | 200 | 167 | 7 | b7f80b2db07119069fbf3d245cf1ad79e8648bab | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.07e-05 | 200 | 167 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.07e-05 | 200 | 167 | 7 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 200 | 167 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.64e-05 | 155 | 167 | 6 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 4.02e-05 | 167 | 167 | 6 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 169 | 167 | 6 | 2341eddfedaad8cee779c37bb87f7def058588ca | |
| ToppCell | facs-Marrow-Granulocytes-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 169 | 167 | 6 | 94871936ccfc73b56d425373b989b87c059d4493 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.58e-05 | 171 | 167 | 6 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 171 | 167 | 6 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 177 | 167 | 6 | b41e975e8368e2618b015be095efe8c0e001c78b | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 177 | 167 | 6 | 15d1de38e4f1a0d4a786d83ee92240f44bdff006 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-05 | 179 | 167 | 6 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-05 | 179 | 167 | 6 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.48e-05 | 182 | 167 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 6.88e-05 | 184 | 167 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.88e-05 | 184 | 167 | 6 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-05 | 184 | 167 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.09e-05 | 185 | 167 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-05 | 185 | 167 | 6 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.30e-05 | 186 | 167 | 6 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 7.52e-05 | 187 | 167 | 6 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.52e-05 | 187 | 167 | 6 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.52e-05 | 187 | 167 | 6 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.52e-05 | 187 | 167 | 6 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.75e-05 | 188 | 167 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 7.75e-05 | 188 | 167 | 6 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 188 | 167 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.75e-05 | 188 | 167 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-05 | 188 | 167 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-05 | 188 | 167 | 6 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 188 | 167 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.98e-05 | 189 | 167 | 6 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.98e-05 | 189 | 167 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 7.98e-05 | 189 | 167 | 6 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | COVID-19_Mild-Treg|COVID-19_Mild / Disease condition and Cell class | 7.98e-05 | 189 | 167 | 6 | f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.21e-05 | 190 | 167 | 6 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.21e-05 | 190 | 167 | 6 | 88c092a5e78ccaddf406f8fff74376bb761b9790 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 190 | 167 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 190 | 167 | 6 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.21e-05 | 190 | 167 | 6 | 4b42a16902d7d1494f953cc88af1e761e76bdf2c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 190 | 167 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.21e-05 | 190 | 167 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-05 | 190 | 167 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 190 | 167 | 6 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.21e-05 | 190 | 167 | 6 | 9501f0995f3d52be90c02b1aa0c7d184bd788c16 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-05 | 190 | 167 | 6 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.45e-05 | 191 | 167 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.45e-05 | 191 | 167 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.45e-05 | 191 | 167 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.04e-07 | 49 | 100 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of SS18 | 2.68e-04 | 62 | 100 | 5 | MORF_SS18 | |
| Computational | Neighborhood of RAP1A | 3.20e-04 | 140 | 100 | 7 | MORF_RAP1A | |
| Computational | Neighborhood of ERBB2IP | 3.35e-04 | 65 | 100 | 5 | GCM_ERBB2IP | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | TFEB CDK17 CDK18 TCF3 MATK RHOBTB2 VPS13A ATXN10 EDRF1 HERC5 | 2.02e-06 | 198 | 166 | 10 | 2279_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.59e-06 | 178 | 166 | 9 | 6454_UP | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.07e-05 | 189 | 166 | 9 | 2790_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.21e-05 | 192 | 166 | 9 | 4110_DN | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.37e-05 | 195 | 166 | 9 | 3286_DN | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 3383_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 3894_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 5243_DN | |
| Disease | Cohen syndrome (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (implicated_via_orthology) | 9.18e-05 | 3 | 164 | 2 | DOID:627 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TCF3 MAP1B ABCA13 SYNE1 MCF2L2 LAMB3 ISLR NXN CHD5 VPS13A OLFM2 IGSF21 EDRF1 | 1.60e-04 | 702 | 164 | 13 | C0009402 |
| Disease | FEV/FEC ratio | CACNA1D CTTNBP2 PABPC4 UTP14A SERTAD2 MEI1 DENND2B CTTNBP2NL USP8 KLHL25 GLIS2 SVIL SYNE2 AEBP2 ATXN10 MAPK3 DNAH5 PTCD3 | 1.74e-04 | 1228 | 164 | 18 | EFO_0004713 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.83e-04 | 4 | 164 | 2 | cv:CN293514 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.83e-04 | 4 | 164 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.04e-04 | 5 | 164 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.04e-04 | 5 | 164 | 2 | C0410190 | |
| Disease | lissencephaly (implicated_via_orthology) | 4.47e-04 | 27 | 164 | 3 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.54e-04 | 6 | 164 | 2 | cv:C0410189 | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 4.54e-04 | 6 | 164 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Congenital muscular dystrophy (disorder) | 4.54e-04 | 6 | 164 | 2 | C0699743 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.54e-04 | 6 | 164 | 2 | C0410189 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 6.33e-04 | 7 | 164 | 2 | C0751337 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.63e-03 | 11 | 164 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 1.63e-03 | 11 | 164 | 2 | C4721541 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.95e-03 | 12 | 164 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Infantile Refsum Disease (disorder) | 2.30e-03 | 13 | 164 | 2 | C0282527 | |
| Disease | Nephronophthisis | 2.30e-03 | 13 | 164 | 2 | C0687120 | |
| Disease | triacylglycerol 46:2 measurement | 2.67e-03 | 14 | 164 | 2 | EFO_0010402 | |
| Disease | Peroxisome biogenesis disorders | 3.07e-03 | 15 | 164 | 2 | C1832200 | |
| Disease | response to peritoneal dialysis, peritoneal solute transfer rate | 3.07e-03 | 15 | 164 | 2 | EFO_0600089, EFO_0600090 | |
| Disease | Adrenoleukodystrophy, Neonatal | 3.07e-03 | 15 | 164 | 2 | C0282525 | |
| Disease | fatty acid measurement | 3.15e-03 | 436 | 164 | 8 | EFO_0005110 | |
| Disease | Zellweger Syndrome | 3.50e-03 | 16 | 164 | 2 | C0043459 | |
| Disease | Intellectual Disability | 3.66e-03 | 447 | 164 | 8 | C3714756 | |
| Disease | Tourette syndrome, schizophrenia | 4.43e-03 | 18 | 164 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | sphingomyelin measurement | 4.73e-03 | 278 | 164 | 6 | EFO_0010118 | |
| Disease | Cleft palate, cleft lip | 4.81e-03 | 279 | 164 | 6 | EFO_0003959, HP_0000175 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 4.93e-03 | 19 | 164 | 2 | EFO_0003100, GO_1902519 | |
| Disease | inferior parietal cortex volume measurement | 4.93e-03 | 19 | 164 | 2 | EFO_0010307 | |
| Disease | triglyceride measurement, body mass index | 4.93e-03 | 19 | 164 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | Squamous cell carcinoma | 5.15e-03 | 124 | 164 | 4 | C0007137 | |
| Disease | Severe Combined Immunodeficiency | 5.46e-03 | 20 | 164 | 2 | C0085110 | |
| Disease | CCL5 measurement | 5.48e-03 | 64 | 164 | 3 | EFO_0005117 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLDPKMSLTGARELL | 336 | Q6UXB8 | |
| SDPLMALQRDFETLK | 51 | Q9P2B4 | |
| TDMADLEELSRLSPL | 6 | Q6ZN18 | |
| SLLDMASKIREDPLF | 126 | Q9NXE8 | |
| VMDKPLDLSDRFSAI | 486 | Q99708 | |
| ELLSDMKADVTRLPS | 1866 | Q8TDI0 | |
| LTSEELLNRMPSKIL | 11 | P30939 | |
| TSPRLIRKALEFMDL | 1526 | Q8N7X0 | |
| EDVSKRLSLPMDIRL | 91 | Q07002 | |
| LLDLMIAKITSDEPL | 246 | Q9UBB4 | |
| DLRDLATSMDSIVKL | 2511 | Q86UQ4 | |
| SSPDAFRTLMLLALE | 246 | P16066 | |
| DLENPMLETASKLLL | 141 | O75179 | |
| MDDEDTLLPRKLQAA | 981 | P78524 | |
| KLVDPERDMSLRLNE | 191 | Q14444 | |
| VLARMDKAVFPSLDD | 81 | P0CG01 | |
| MAADQRPKADTLALR | 1 | Q8IUZ5 | |
| PATSDIKDVDSLMRI | 201 | Q9Y2Q0 | |
| MALILLKEDSLDATR | 726 | Q9NTI2 | |
| TAILEKAANDPLMRA | 241 | Q8IYR0 | |
| EVIARPASLSNDKLM | 321 | Q8WWK9 | |
| SPLIAEREAMKSSEL | 676 | P15918 | |
| ALDFSAMLPKIAVRD | 406 | Q6ZP01 | |
| RLKVMLADSPREESN | 456 | Q8IUH3 | |
| ELKDRMTELLPLSSV | 121 | O95897 | |
| SARIKMEEDALLSDP | 461 | Q6ZRI8 | |
| KLAMLEEDLLALKSP | 221 | Q6NVY1 | |
| MLLASILTPSVEADK | 786 | Q9Y5F8 | |
| MLESPESLRSKVDEA | 596 | P11940 | |
| LAELVPRLFRMASKD | 56 | Q9UN73 | |
| ELVSDFDRKELMNPL | 241 | Q8N7Z5 | |
| FDRKELMNPLSDSLS | 246 | Q8N7Z5 | |
| RTSMETALALEKLFP | 126 | Q8NEZ5 | |
| ELLHMLESPESLRSK | 601 | Q13310 | |
| PRSELLNELMDSAKV | 606 | Q96EY7 | |
| LESMPSVRLLLLKDN | 166 | Q9HBL6 | |
| REREALSADPKLSLM | 106 | P42679 | |
| KELEAERSLMSSPED | 821 | P46821 | |
| DRIAESLDMPKASLL | 166 | Q8TD90 | |
| LIMDDDRTVDPLLSK | 321 | Q49MG5 | |
| LMLLRLTEPADTITD | 121 | P06870 | |
| RPLSMDLTARFENKE | 281 | Q9BY89 | |
| ADASPSLNREEVMKL | 1141 | Q3B7T1 | |
| KILEREDARLMFTSP | 2211 | Q13439 | |
| ARASLERLVKEMAPL | 441 | Q9BQS8 | |
| SDLELDPMKDILILS | 406 | Q53G44 | |
| ADLLPKLKSMALADR | 401 | Q8NHQ9 | |
| LLKMDSNELTFIPRD | 126 | O14498 | |
| TAELPRSMLSTEDLL | 226 | Q86YR7 | |
| ILMSPSAKELVLRSE | 351 | Q14642 | |
| LLMADQDSPLDLTVR | 56 | Q96JN0 | |
| IKLLNETRDMLESPD | 261 | P56589 | |
| SRAPQTFKMDDLLAE | 76 | P50542 | |
| MDASLEKIADPTLAE | 1 | Q6P996 | |
| MDASLEKIADPTLAE | 1 | Q6P474 | |
| MAEPLEKLLSRSLQR | 36 | O94915 | |
| RASPQAADLLEKMLE | 276 | O15264 | |
| PLLASIARELSKMAQ | 266 | A6NHZ5 | |
| PADSMLLDLERTLML | 256 | Q7L4E1 | |
| TRDMIDNLLSPDLID | 161 | P07093 | |
| SKALDLLDRMLTFNP | 301 | P27361 | |
| ISMEDLNKRLSLPAD | 136 | Q00537 | |
| LMKLARPAVLDDFVS | 581 | P14210 | |
| AATRAKLRPSMDEVL | 426 | Q9Y616 | |
| MHSLDEPLDLKLSIT | 1 | Q9BZE0 | |
| LALSSDKIAALRMPL | 126 | Q9NX08 | |
| PKNVARMLALALAES | 1036 | A7KAX9 | |
| SSLRPLLNKDMSSEE | 1266 | Q9C091 | |
| LPASEIAKLLASDDM | 361 | Q96PQ7 | |
| DHERLSKMLSLPEEL | 496 | Q9P0J1 | |
| ATEAMAPDILARKLA | 91 | P41236 | |
| SLDRLPKTRSMDDLL | 601 | Q9NYA4 | |
| MLESPESLRSKVDEA | 591 | Q9H361 | |
| EKMLALTLAKADSPR | 991 | Q5TIA1 | |
| LALLMKEAELRGSPS | 206 | O76062 | |
| LLDQMPSLEDLKELS | 796 | Q9UII4 | |
| DLKPEQSVRDSMDSL | 526 | Q96MT3 | |
| RMLRLSLNIDPDAKV | 741 | P14625 | |
| KIPSARSLDEIAMDL | 366 | Q9Y2L6 | |
| PFRSLLHRDLDDTKM | 211 | Q96ID5 | |
| RMSAELTVLDEPLKF | 316 | Q8N9C0 | |
| LKDAQMRDLLSPPTD | 1186 | Q8NHM5 | |
| SSEALLMADERTKLI | 251 | Q9H0H3 | |
| NLKMLISAASPDIRD | 86 | Q96AV8 | |
| MATAATSPALKRLDL | 1 | Q8WTW3 | |
| FDVDTLSKSELRMLL | 31 | Q8WZ74 | |
| AESRKLLLREPVDAM | 226 | Q53HC0 | |
| LLSDMKADVTRLPAT | 1871 | Q12873 | |
| ELTPAERDDLASIMK | 266 | P07902 | |
| LKEDPATMSLLQRSL | 456 | O15063 | |
| HSDRLLELKSPTELM | 2451 | Q5VT06 | |
| ARPEARTLQKDMADL | 121 | Q9P203 | |
| LRANSPTMDKLLADS | 946 | O95466 | |
| MKDFPLNDLLSATEL | 336 | Q14204 | |
| DLLSEAIPESLKNML | 1661 | Q92538 | |
| FLLTRLNDPKMSETE | 291 | Q9P0J7 | |
| DLTMHPLKALEDLSE | 81 | A0A0U1RQI7 | |
| KLVALRLEMSSLPDL | 766 | Q13751 | |
| ISPANEKTLLSEDMR | 196 | Q6PII3 | |
| LRKDSASRLVPEVML | 341 | Q13683 | |
| AMEALARRILSKPIE | 566 | Q7L014 | |
| LSDMKADVTRLPATI | 1861 | Q14839 | |
| SADPELALALRVSME | 211 | P55036 | |
| KDMLLAFPNDRAATI | 581 | Q6ZTR5 | |
| LSRLGPSLRDKDLEM | 66 | Q5VV67 | |
| LKDMDPSELVEALRT | 681 | P20648 | |
| IMLSSAALAAEDPIR | 896 | Q01668 | |
| MESPKEALSAQSRDL | 1761 | Q5VW36 | |
| PIKDLDDIRIAMAAL | 1246 | Q8TE73 | |
| SLDHIKELLMETRSP | 386 | Q2NKX8 | |
| KELLMETRSPLAELG | 391 | Q2NKX8 | |
| ALDIKSADPEVMLLT | 1226 | Q2NKX8 | |
| LLAQMRKDTDDIESP | 156 | Q9UPQ0 | |
| PRNLSLMDKLLDLDD | 366 | Q96BN6 | |
| LDLDDKLLMRPGSST | 376 | Q96BN6 | |
| DPLRVSSRDKLTEMA | 26 | Q9BWH2 | |
| SMANPEELDKLISDR | 296 | Q96NZ1 | |
| RTELEMLSDKSLSLP | 2141 | P46939 | |
| DMLANLRDVDELPSL | 356 | O43815 | |
| PSLSKKDLDLMLLDD | 426 | P19484 | |
| SLMPKLIDLEDSADV | 366 | Q96D71 | |
| RPDMQLESDLKLDRL | 1256 | O95425 | |
| LKFSSMAPDLDRLNE | 7401 | Q8NF91 | |
| NLTDVSPDLDIRLKM | 836 | Q8WXH0 | |
| ALESFAKMIPLLRES | 826 | Q6ZUX3 | |
| AAPLLTILDMSARAK | 391 | Q6DKJ4 | |
| SPDLDDMKLIILANR | 566 | Q9BYZ6 | |
| LEVSLSRDSPLKTLM | 361 | Q8NCF5 | |
| PFARAKDLSVLMDRL | 1331 | O60287 | |
| LSLTTKMDAEHPELR | 191 | Q12765 | |
| DLRLESPTRSLSMDA | 191 | Q13326 | |
| RMLDESDLLKTLPTT | 491 | Q9NQW8 | |
| LRAAQEMARKLSELP | 671 | P35523 | |
| LLTMSLERDLLDAEP | 721 | Q9BXU1 | |
| LERDLLDAEPMKELS | 726 | Q9BXU1 | |
| RALALPDKVLLEDAM | 276 | Q8IZ63 | |
| AISKEIFAPLDERML | 6 | Q8NFX7 | |
| MSTDKAPLRQLLDAT | 1101 | Q9P217 | |
| KPRLLSSLDDAMSLF | 551 | Q96RL7 | |
| ITEDLSLADLMPRVK | 86 | P42285 | |
| RMAPVGTDKELSDLL | 6 | P15923 | |
| PQESRADDSKLMDSL | 211 | Q14140 | |
| LKSPDADSDQLFRMV | 3281 | Q15413 | |
| DAMVDLLDLDPLKRS | 1156 | O94759 | |
| IRMSPEELASKELAA | 1011 | Q92576 | |
| KTMDLPFLEASTLRA | 226 | P19174 | |
| AMEPELADTSALKAA | 96 | O14492 | |
| PVEKASLRAMSLEEA | 206 | Q9BVJ6 | |
| LTNEDFRKLLMTPRA | 31 | Q13123 | |
| RDLLPSSAMIKDLSQ | 381 | Q6ZUG5 | |
| DDFMLVIRSIPDKSS | 1281 | Q9ULM0 | |
| DSPLETKMAVLALLA | 1636 | P78527 | |
| PDLAEMSLDDSSLAL | 616 | A7E2V4 | |
| NVARSLLMERDALKP | 436 | Q5R3I4 | |
| SDPLKLVRDAMEETT | 86 | Q13061 | |
| MSLDKAPLRQLLDAT | 1131 | Q9HCJ5 | |
| IADMALDPAKKLLLT | 171 | Q9H6Y2 | |
| NESRKPESLLAPDLM | 911 | Q7Z7G8 | |
| LSRLEQPDLSSEMSK | 76 | Q8WUA4 | |
| AALVSPISKSMLERL | 31 | Q6XPS3 | |
| ALQRALEMSLAETKP | 201 | Q8WV99 | |
| LDPEKQADMLDSLRI | 1816 | Q9Y4A5 | |
| FSPTLMLTDEEKARI | 451 | P40818 | |
| ELPDFSMLKRLARDQ | 11 | Q9H267 | |
| LKCPMDLLARDAPDT | 126 | Q12836 | |
| DIMLLRLARPAKLSE | 106 | Q92876 | |
| LLKDFPDELRSDITM | 526 | Q96L42 | |
| SLMALADFDEPKRST | 81 | A6NI61 | |
| LLLSPDVTDRKLTME | 631 | P57103 | |
| SLAAVKILDPVSDMD | 51 | Q8WXR4 | |
| LKPMSIISLLDEESR | 501 | Q6PIF6 | |
| LAESIKSMNLRPEED | 631 | Q14CX7 | |
| SDLAEEPAMKDLLLE | 161 | O60237 |